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Abstract 
Collagen-coated small unilamellar liposomes were prepared by incubation of two hydrophobic derivatives of collagen (average M,. 
50 000) with preformed vesicles. The introduction of hexyl and lauryl residues to the collagen molecule improved by I 0-fold the ability of 
collagen to coat liposomes. In vitro stability of the different coated vesicles prepared, was studied by their ability to retain entrapped 
carboxyfluorescein as a function of the time. Coated vesicles were clearly more stable in vitro than control iposomes, except for those 
containing the lauryl derivative in a protein/phospholipid weight ratio higher than 10 -3. Vesicle clearance from circulation as well as 
tissue distribution were also determined. Pharmacokinetics (determined by both fluorescence and radioactive techniques) were highly 
dependent on the injected dose, phospholipids used and the content of collagen. Half-lives were maximum for liposomes composed of 
saturated phospholipids injected at a dose of 2 /xmol phospholipid. Besides, blood elimination of collagen-containing vesicles was about 
2-fold faster and liver uptake 1.5 to 2-fold higher than control iposomes. 
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1. Introduction 
The problem of binding proteins to liposomes has been 
given increasing attention mainly because the attachment 
of some specific proteins to the surface of liposomes has 
proved useful in creating homing devices able to deliver 
drugs to a target group of cells or tissues [1]. 
Besides, it has been well established that the incorpora- 
tion of certain molecules to the liposome membrane can 
alter their in vivo behavior, thus providing great versatility 
for liposome therapeutic applications. It is well known that 
liposomes are rapidly cleared from circulation mainly due 
to two processes: (a) lipid exchange with high-density 
lipoproteins (HDL) [2], leading to liposome disintegration, 
and (b) opsonization followed by macrophage uptake [3,4]. 
However, the presence of cholesterol [5,6], gangliosides [7] 
and - more recently - poly(ethylene glycol) [8-13] has 
proved to reduce the rates of these interactions, resulting in 
enhanced circulating times. On the contrary, other compo- 
Abbreviations: Fmoc, 9-fluorenylmethoxycarbonyl; Gl , glycine; pfp, 
pentafluorophenyl; HOBt, 1-hydroxybenzotriazole. 
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nents, such as phosphatidylserine [14] or certain poly- 
saccharides [15] have proved to promote liposome clear- 
ance from circulation. 
It seems well established that the beneficial effect of 
PEG or gangliosides on prolonging half-life is due to the 
fact that they provide a hydrophilic shelter around the 
external ayer of liposomes hindering the attachment of 
plasma proteins to its surface. Following this assumption 
we explored the possibility of using a widely spread 
protein (collagen) to provide the same sterical effect. In 
addition, as collagen plays an important role in the cell 
adhesion process it could also be possible that it facilitates 
the binding of liposomes to ceils. 
As a first approach, in this paper we report the results 
obtained after incorporation of hydrophobically derivatized 
collagen to the surface of liposomes as far as its stability 
and biodistribution is concerned. 
2. Materials and methods 
2.1. Materials 
Collagen used in this study was kindly provided by 
Lipotec (Spain). The average molecular weight determined 
by SDS-PAGE electrophoresis [16] was 50000. Hydro- 
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genated phospholipids (HPC), consisting in a mixture of 
hydrogenated egg phosphatides (type V) that contained 
more than 75% of phosphatidylcholine, were from Asahi. 
Natural phosphatidylcholine (PC) was supplied by Avanti. 
Cholesterol purchased from Sigma. Carboxyfluorescein 
(CF) (Eastman Kodak) was purified by column chromatog- 
raphy. Fmoc-Gly-Opfp and HOBt were supplied by Nov- 
abiochem. Diethylenetriamine p ntaacetic acid disteary- 
lamide complex (DTPA-SA) was synthesized and 
[111In]DTPA-SA prepared as reported by Kabalka [17]. 
2.2. Methods 
2.2.1. Labeling procedure 
In order to increase the affinity of the protein for 
liposome bilayers, hydrophobic derivatives of collagen 
containing hexyl or lauryl residues were synthesized as 
reported elsewhere [18]. Furthermore, native collagen (C) 
as well as the hexyl (C-H) and lauryl (C-L) derivatives 
were fluorescently labeled by chemical linkage of the 
9-fluorenylmethoxycarbonyl (Fmoc) moiety. In brief, to a 
solution of 1 g of collagen or collagen derivative in 5 ml 
of distilled water, Fmoc-Gly-Opfp and HOBt (dissolved in 
N,N-dimethylformamide) were added in amounts 
equimolecular tothe assumed number of free amino groups 
present in the protein, as estimated by reaction with 2,4,6- 
trinitrobenzenesulfonic acid. After 4 h of reaction at room 
temperature, the reacting mixture was lyophilized. The 
residue was washed with DMF and the absence of Fmoc 
amino acid and HOBt was controlled by TLC. Fluores- 
cence intensity of the collagen derivatives was measured at 
excitation-emission wavelengths of 265-305 nm on a LS 
50 Perkin Elmer spectrofluorimeter. In some experiments 
collagen was radiolabeled with 125I by the IodoGen method 
(Rockford, IL). 
2.2.2. Preparation of collagen-coated liposomes 
2.2.2.1. Fluorescently labeled liposomes. Small unilamel- 
lar vesicles composed of HPC/Chol (1:1 molar ratio) were 
prepared in the presence of 50 mM carboxyfluorescein 
(CF). In brief, the dry lipid film on the walls of a flask was 
hydrated with a solution of the marker in acetate buffer 
(pH 7.4) at 55°C and subsequently sonicated and allowed 
to stand for 1-2 h at the same temperature. SUV were 
separated from free CF by column chromatography in 
Sephadex G-50 followed by dialysis. Liposomes thus pre- 
pared were incubated at room temperature for 6 h with a 
solution of one of the different collagens (C, C-H and C-L) 
in a weight ratio of 0.4 mg collagen per mg phospholipid. 
In the case of C-L weight relationships of 0.2 (C-L0. 2) and 
0.1 (C-L0.1) mg collagen per mg phospholipid were also 
assayed. Coated liposomes were isolated by gel permeation 
chromatography on Sepharose CL 6B and the effectiveness 
of the coating was controlled by fluorescence t chniques. 
Fractions that were fluorescent both, at excitation-emission 
wavelengths of 490 and 520 nm, respectively (conditions 
for the detection of CF) and at 265-305 nm (detection of 
Fmoc group) were considered to contain collagen-coated 
liposomes. Mean diameter of all preparations were within 
the range 115-135 nm. 
2.2.2.2. Radioactively-labeled iposomes. In this case lipo- 
somes of PC/Chol (1:1 molar ratio) composition were 
prepared by hydrating a thin lipid film containing a trace 
amount of [HIln]DTPA-SA with an isotonic solution of 
PBS (pH 7.4) for 1 h at room temperature. Then, lipo- 
somes were incubated overnight with a C-H solution with 
trace amount of [125I]C-H in a phospholipid:protein weight 
ratio of 0.4:1. Excess of protein was eliminated by centrif- 
ugation for 30 min at 100000 × g. Thus obtained colla- 
gen-coated liposomes were then extruded through two 
stacked polycarbonate filters of 200 nm pore size. As 
reference non-coated liposomes were also prepared. The 
mean diameter, measured by dynamic laser light scatter- 
ing, was 193 _+ 62 nm for non-coated vesicles and 190 _ 32 
for collagen-coated liposomes. 
2.2.3. In vitro stability studies 
Incubations of the different liposomal preparations based 
on hydrogenated phospholipids, viz., non coated liposomes 
and liposomes coated with native collagen or C-H or 
C-L0. 4, C-L0. 2, C-Lo. ~ were carried out at 37°C. Samples 
were taken at different time intervals and fluorescence 
measured before and after Triton X-100 treatment (Aex: 
490, Aem: 520). Latent CF of the different liposomal 
preparations expressed as a function of the incubation 
time, was determined. Furthermore, liposomes used for the 
in vivo experiments (PC/CHOL, 1:1), namely, uncoated 
liposomes and liposomes coated with the hexyl derivative 
of collagen containing CF were incubated at 37°C in the 
presence of 5 volumes of prewarmed rat plasma so as to 
simulate dilution in blood after intravenous injection. At 
time intervals samples were assayed for latent CF and 
mean vesicle size was determined. 
2.2.4. In vivo experiments 
2.2.4.1. Administration of fluorescently-labeled liposomes. 
Female B6D2F mice weighing 20-30 g were injected 
intravenously with 0.1 ml of the liposomal preparations 
(lipid composition: HPC/Cbol 1:1, molar ratio) that 
showed stable in the stability studies (dose of 0.2 /xmol 
phospholipid). Five animals were used for each prepara- 
tion. At time intervals after injection, 25 /xl of blood was 
collected from the tail vein in calibrated heparinized glass 
micropipettes and rapidly mixed with 1 ml cold PBS. 
Immediately after, the diluted samples were spun at 1700 
× g for 10 min and supernatants analyzed for CF in the 
presence of Triton X-100 (1% final concentration). Total 
CF in the blood was expressed as percent of the injected 
dose. Plasma concentration f CF, calculated by means of 
a calibration curve, versus time was individually fit to 1-, 
2- or 3-compartment models with first-order elimination 
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by using least-squares linear regression on a ESTRIP 
program. According to correlation coefficients and the sum 
of squares, data were best fit to a two-compartment open 
model. Pharmacokinetic parameters of the different formu- 
lations were statistically compared by means of the non 
parametric Kruskall Wallis test. Differences were consid- 
ered significant at P < 0.05. 
2.2.4.2. Radioactively-labeled liposomes. 111 In-labelled 
non-coated liposomes and liposomes coated with the hexyl 
derivative of collagen (lipid composition: PC/Chol 1:1, 
molar ratio) were injected i.v. into female CD-1 mice 
weighing 20-25 g at a dose of 0.2 and 2 /xmol phospho- 
lipid. At specified time intervals, mice were anaesthetized, 
bled by retroorbital puncture, and then sacrificed by cervi- 
cal dislocation and dissected. Blood and major organs 
including spleen, liver, lung, heart and kidneys were col- 
lected and weighed. Three animals were used per sample 
and time point. Clearance from circulation and biodistribu- 
tion of liposomes were determined by analysis of 11 lin 
radioactivity in blood and each organ using a Beckman 
gamma-counter. Liposome levels in the blood were deter- 
mined by assuming that the blood volume of the mouse is 
7.3% of the total body [19]. 
For intrahepatic distribution studies male Wag/Rij rats 
(TNO, Rijswijk, The Netherlands), weighing 220-260 g 
were injected intravenously (penis vein) with 5 /zmol of 
liposomal phospholipid in less than 1 ml of Hepes-buffered 
NaC1, pH 7.4. In this case liposomes were radiolabeled 
with a tracer amount of [3H]cholesterol oleylether 
(Amersham), which was included in the lipid mixture 
during liposome preparation. 16 h after injection, the ani- 
mal was anesthetized with diethylether, a blood sample 
was taken from the tail vein, the spleen was removed and 
homogenized and the liver was flushed in situ with saline 
to remove blood. Total uptake of liposomes by liver and 
spleen was determined by measuring radioactivity in the 
total liver cell suspension obtained uring cell isolation or 
in the spleen homogenate, respectively. For hepatocyte and 
macrophage isolation the liver was perfused with collage- 
nase or pronase and parenchymal nd non-parenchymal 
cell fractions were isolated as described by Scherphof and 
co-workers [20,21]. The number of cells per fraction was 
determined microscopically and radioactivity of each frac- 
tion was determined. From these data the total amounts of 
radioactivity per cell population, after correction for % 
recovery, were calculated [20]. 
3. Results and discussion 
3.1. Preparation of collagen-coated liposomes 
Among the different methods described as useful for 
binding proteins or other polymers to liposomes, here we 
have chosen one of the simplest o incorporate collagenous 
Table 1 
Collagen content in the different coated liposomes 
C(o.4) C-H(o.4) C-L(o.4) C-L(o.2) C-L(o.l) 
/zg/mg PL 0.46 5.75 4.91 1.88 0.76 
Collagen, either in native state or derivatized with hexyl or lauryl residues 
was incubated with preformed unilamellar liposomes (HPC/Chol 1:1 
molar ratio) prepared by sonication. Effectiveness of coating was deter- 
mined by fluorescence techniques (Aex: 265 nm, Aem: 305 nm) (* mg 
collagen per mg phospholipid uring the incubation with liposomes). 
fragments to liposome bilayers. For this purpose, two 
hydrophobic anchors, consisting of fatty acid chains of 6 
and 12 carbon atoms, have been incorporated to a certain 
number of the protein primary amino groups. Subse- 
quently, these collagen derivatives have been incubated 
with preformed small unilamellar vesicles. In collagenous 
fragments of average molecular weight 50000, about 10 
lysines (2.5% of total aminoacids), in addition to the 
terminal amino groups, are expected per fragment. There- 
fore, the protein will, presumably, be anchored by several 
points to the vesicles membrane. Furthermore, as the at- 
tachment takes place after formation of the vesicles, the 
protein is expected to become grafted just in the outer half 
of the bilayer. 
Collagen-coated vesicles were isolated from excess of 
protein by gel-filtration chromatography. Similar elution 
diagrams were obtained for liposomes coated with native 
collagen or the hexyl or lauryl derivative. The content of 
collagen in the different protein-liposome systems was 
calculated by fluorescence t chniques as described in Sec- 
tion 2. According to Table 1, the efficacy of collagen 
binding to preformed liposomes was increased about 10- 
fold by incorporating hydrophobic hains to the protein 
molecule. Thus, when native collagen was used 0.46/xg of 
protein were bound per mg phospholipid, while in the 
same conditions, about 5 /xg of C-H and C-L per mg 
phospholipid remained associated to the vesicles. It is 
noteworthy that when liposomes composed of unsaturated 
phospholipids were incubated with the hexyl derivative of 
collagen a similar amount of protein became attached to 
the vesicles (4.5 /xg/mg phospholipid). Torchilin et al. 
[22] obtained similar results (4.7- 10 -5 mol protein per 
mol lipid) in the binding of a hydrophobic derivative of 
a-chymotrypsin to liposomes (initial protein/lipid molar 
ratio 1:100). Table 1 also shows that although most of the 
protein did not take part in the coating process, increasing 
amounts of collagen in the incubation media lead to a 
higher content of protein in the final liposomal preparation. 
3.2. In vitro stability studies of collagen-coated liposomes 
The effect hat coating the vesicles with native collagen 
or its hydrophobic derivatives had on their permeability 
was studied using carboxyfluorescein as a model entrapped 
solute. When liposomes become leaky, entrapped CF es- 
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Fig. 1. In vitro stability at 37°C of control ( -• - )  and liposomes coated 
with native collagen ( + ), hexyl collagen (- × -) and C-L0. 4 (- [] -), C-L0. 2 
( -• - )  and C-L0.1 (-,x _). Lipid composition in all cases was HPC/Chol 
(1:1 molar ratio). 
capes into the medium to attain concentrations which 
allow it to fluoresce, according to its ability to self-quench. 
In our present work, coated and non-coated liposomes 
containing quenched CF and composed of HPC/Chol (1:1 
molar ratio) were incubated at 37°C and CF latency values 
after several time intervals were determined (Fig. 1). Lau- 
ryl collagen containing liposomes were clearly more unsta- 
ble than non-coated liposomes, except for those whose 
protein/phospholipid ratio was lowest. 
In a previous work [18] we found that the lauryl deriva- 
tive of collagen showed at concentrations over 0.2 /zM, 
both a surface activity and interaction with phospholipids 
(monolayers and bilayers) lower than expected according 
to its hydrophobicity, thus indicating the presence of highly 
stable internal aggregates or micelles. In the present exper- 
iment the concentration f the protein C-L derivative in the 
incubation media was in all cases lower than 0.05 /~M; 
therefore, in this highly diluted media, the presence of 
aggregates can be discarded and it is reasonable that the 
more hydrophobic derivative (C-L) show at identical con- 
centrations a stronger interaction with liposomes than the 
hexyl derivative (C-H), and in consequence induce an 
increased leakage of the entrapped marker. 
In addition to liposomes coated with C-L0 l, liposomes 
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Fig. 2. Comparison of the clearance of collagen-coated and non-coated 
vesicles from the circulation of mice. SUV ( ~ 100 nm) of composition 
HPC/Chol (1:1 molar ratio) either coated with C (D), C-L (z~), C-H 
((3), or unmodified (T)  were injected intravenously into mice (0.2 /xmol 
phospholipid/25 g mouse). Total blood levels of CF (% dose + S.D. five 
animals) based on an assumed blood volume of 7.3% of the total body are 
shown. 
containing native collagen and C-H also showed a higher 
stability than those of reference, the former showing la- 
tency values twice as high as the latter after 144 h of 
incubation at 37°C. These results are in agreement with 
those reported by Pajean and Herbage, who suggested that 
the presence of collagen decreased liposomes CF leakage 
at low temperature [23]. Moreover, Sunamoto and co- 
workers also reported a decrease in the permeability of 
liposomes after coating their outer surface with some 
hydrophobic derivatives of polysaccharides [15]. 
3.3. Vesicle clearance from circulation 
Fig. 2 shows that plasma concentration of liposomes 
coated with native collagen were similar to those observed 
for non-coated vesicles of the same lipid composition 
(HPC/Chol 1:1 molar ratio) and characteristics (size about 
100 nm; dose of 0.2 /zmol phospholipid). This may indi- 
cate that the protein is so weakly bound to the vesicles, 
that in contact with the biological fluids becomes detached. 
Table 2 
Effect of the different collagen coatings in the pharmacokinetic variables of liposomes 
Variables Collagen used for coating 
~b C C-H C-L 
t~/2 ~,(h) 0.458 (0.39) 0.784 (0.42) 0.818 (0.31) 0.374 (0.20) 
tL/2~(h) 7.99 (1.05) 7.42 (1.02) 9.46 (1.75) 6.97 (1.44) 
K~ (h-~) 0.133 (0.01) 0.201 (0.03) 0.304 * (0.07) 0.220 * (0,01) 
CI (ml/min kg) 0.218 (0.06) 0.294 (0.02) 0.940 * (0.26) 0.309 (0.11) 
V o (1/kg) 0.097 (0.02) 0.087 (0.01) 0.194 * (0.07) 0.084 (0.03) 
Liposomes containing CF (0.2 /a, mol phospholipid/mouse) with defined size and composed of HPC/Chol (1:1 molar ratio) were i.v. rejected into mice. 
Blood samples (25 /xl) were collected at different ime intervals after injection and latent CF was determined (Aex: 490 nm and Aer.: 520 nm). Data 
represent average values (S.D.) of five mice. 
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Another possible xplanation for this fact is that the amount 
of native collagen attained in the liposome surface (0.46 
/~g/mg phospholipid) is not enough to exert any type of 
effect on the in vivo behavior of the vesicles. 
Liposomes coated with C-L also lead to plasma concen- 
trations similar to those of the control liposomes. How- 
ever, the curve corresponding to liposomes coated with 
C-H was remarkably different. In that case, a rapid de- 
crease in the plasma levels was observed uring the first 
minutes. Thus, 30 min after injection just 30% of the 
injected dose could be found in the blood, while at the 
same time, 60% of the injected control iposomes remained 
in circulation. We consider that the differences observed 
between the preparations containing the two hydrophobic 
derivatives are due to the different protein concentration i
the liposome surface, 5.75 /~g/mg phospholipid in the 
case of C-H and just 0.76 in C-L containing liposomes. A
higher concentration of C-L was not used in the in vivo 
experiments, ince it could induce to a destabilization of 
the vesicles, as observed in the in vitro stability studies. 
Pharmacokinetic parameters of these data are given in 
Table 2. The elimination half-life of all preparations were 
not significantly different (P> 0.05). However, differ- 
ences on other parameters also related to the clearance 
from circulation, such as the elimination rate constant 
(Ke l )  or  the total systemic learance (C1) were significant 
(P  < 0.05) between liposomes coated with C-H and the 
other preparations assayed, the higher values correspond- 
ing to the former. Hexyl-collagen coated liposomes also 
showed a greater volume of distribution, thus indicating 
that this kind of liposomes distribute in a greater extent o 
tissues. 
Circulation time of liposomes composed of unsaturated 
phospholipids (PC/Chol, 1:1 molar ratio), either coated 
with hexyl-collagen or unmodified, were also studied. In 
that case, when the same dose as before was injected (0.2 
/xmol phospholipid), no significant differences were ob- 
served between the two preparations (Fig. 3), elimination 
half-lives being 0.91 + 0.21 and 0.96 + 0.27, respectively. 
However, when the dose of injection was increased 10-fold, 
again liposomes coated with C-H were more rapidly cleared 
from the blood than those of reference. 
The results above described also give information about 
other parameters affecting circulation time of liposomes. In 
complete agreement with bibliographic data [24-26], our 
results indicate that liposomes remain longer in the blood 
when a higher dose of lipid is injected (Fig. 3). Most 
authors agree that this dose-dependence is a consequence 
of the saturation of the mononuclear phagocytic system, 
responsible for the uptake of most of circulating lipo- 
somes. This saturation of the MPS, especially Kupffer 
cells located in the liver, is evidenced in our own results 
by an increase in the vesicles plasma levels and a decrease 
in the percentage that accumulates in liver as will be 
Table 3 
Effect of the collagen coating in the distribution of liposomes 
(A) % Injected dose 
Time (h) uncoated vesicles vesicles coated with hexyl-collagen 
blood spleen liver lung heart kidneys blood spleen liver lung heart kidneys 
0.08 62.36 2.38 16.7l 2.09 1.70 2.72 63.09 3.36 32.78 1.52 1.05 1.84 
(6.07) (0.19) (0.58) (0.41) (0.34) (0.52) (5.24) (0.30) (6.55) (0.21) (0.52) (0.36) 
0.5 44.78 6.00 24.43 1.75 1.26 1.80 32. I 1 8.76 45.88 1.28 0.56 1.47 
(3.72) (0.60) (1.92) (0.41) (0.46) (0.34) (0.28) (3.38) (5.58) (0.34) (0.13) (0.23) 
1 34.99 8.25 29.25 1.27 1.09 1.67 14.65 10.98 50.22 0.57 0.27 0.95 
(1.63) (0.52) (3.48) (0.27) (0.07) (0.17) (5.78) (1.75) (4.45) (0.23) (0.07) (0.35) 
6 7.66 8.31 51.86 0.52 0.18 1.06 3.79 12,72 64.35 0.30 0.14 0.75 
(0.88) (1.79) (1.42) (0.06) (0.05) (0.06) (0.68) (1.64) (5.58) (0.07) (0.03) (0.05) 
(B) % Injected dose 
Time (h) uncoated vesicles vesicles coated with hexyl-collagen 
blood spleen liver lung heart kidneys blood spleen liver lung heart kidneys 
0.08 45.12 3.17 26.34 1.28 1.13 1.89 34.60 7.18 51.75 1.43 0.89 1.10 
(0.81) (0.31) (2.43) (0.13) (0.43) 0.05) (1.59) (1.93) (4.31) (0.17) (0.51) (0.09) 
0.25 27.35 9.99 40.95 0.95 0.47 1.29 16.24 10.09 65.73 0.85 0.27 0.81 
(0.29) (1.23) (0.08) (0.13) (0.11) (0.17) (3.40) (0.46) (4.23) (0.25) (0.06) (0.27) 
0,5 19.33 10.72 41.06 0.70 0.49 1.11 12.93 14.75 65.37 0.80 0.23 0.67 
(4.58) (3.44) (4.98) (0.27) (0.12) (0.48) (4.73) (3.22) (4.24) (0.3 l ) (0.09) (0.3 l) 
1 12.97 14.01 39.14 0.55 0.38 0.74 3.71 14.15 68.42 0.46 0.11 0.36 
(3.46) (1.14) (2.07) (0.13) (0.09) (0.20) (0.67) (4.08) (9.74) (0.26) (0.02) (0.12) 
3 2.97 9.99 48.02 0.24 0.12 0.43 1.58 12.76 77.73 0.25 0.06 0.27 
(1.40) (2.56) (2.74) (0.19) (0.05) (0.08) (0.65) (3.81) (4.11) (0.05) (0.02) (0.07) 
~l Iin_labeled liposomes with defined size and composed of PC/Chol liposomes were i.v. injected into mice. Phospholipid injected dose was 2 (A) or 0.2 
(B) /zmol. At different ime points after injection mice were killed and the I I I In radioactivity in each organ was counted. 
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Fig. 3. Clearance from circulation of C-H coated (n )  and control 
liposomes (zx) (lipid composition: PC/Chol 1:1, molar ratio) after the 
injection of 2 (filled symbols) or 0.2 (hollow symbols) /zmol phospho- 
lipid. Values are percentage + S.D. of injected dose. 
detailed in next section. This work also shows that lipo- 
somes of similar size and identical dose of injection re- 
mained longer in the blood when saturated phospholipids 
are used in the composition of liposomes. Thus, a half-life 
of 7 h was obtained for liposomes composed of HPC/Chol 
compared to about 1 h for PC/Chol liposomes. This fact 
has also been well-established by other authors [5,27-29]. 
3.4. Tissue distribution of collagen-coated vesicles 
We then examined whether collagen attachment to lipo- 
somes affects their tissue distribution. Although carboxy- 
fluorescein has proved to be a good marker for vesicle 
clearance [30], it is not appropriate to measure its distribu- 
tion in tissues. For such a purpose, u ~In has often been 
used, either associated to an aqueous solute [30] or to a 
lipidic component of liposomes [31]. This marker has the 
advantages that is retained by tissues for several days, is 
unable to reach tissues significantly by itself, and can be 
conveniently measured in a gamma counter. For this rea- 
son, in this study Ulln has been used as a marker of the 
lipid phase of liposomes. Liposomes composed of PC/Chol  
(1:1 molar ratio) either coated with the hexyl derivative of 
collagen or uncoated were prepared by the extrusion 
method, since sonicated liposomes have been reported to 
be not homogenous enough for this kind of experiments 
[32]. These formulations were injected i.v. at a dose of 0.2 
and 2 /zmol phospholipid and the biodistribution was 
examined at different time intervals. A comparison of 
conventional liposomes or liposomes coated with C-H are 
given in Table 3A and B. 
For both doses assayed, collagen coated liposomes had 
substantially higher levels in liver than control liposomes 
at all time points. On the other hand, in both cases the 
accumulation of liposomes in liver was lower when the 
higher dose of phospholipid was injected, probably due - 
as explained before - to the saturation of MPS. Thus, 1 h 
after injection of 2 and 0.2 /zmol phospholipid of control 
liposomes, 29% and 39% of the injected dose was recov- 
ered in this organ, respectively. Likewise, 50% and 68% 
was found after administration of the same doses of lipo- 
somes coated with collagen. 
The higher levels observed in liver for the collagen- 
coated vesicles, were accompanied by lower concentra- 
tions in blood and other organs, such as heart, lung and 
kidneys. With regard to the concentrations observed in 
spleen, no significant differences were detected between 
coated and non-coated vesicles. 
To be sure that the higher accumulation in liver ob- 
served for collagen coated vesicles was not due merely to 
an increase in size of those liposomes in circulation, their 
stability in the presence of plasma was studied. For that 
purpose, liposomes with the same composition and size as 
those used for the biodistribution studies were prepared 
containing CF as an entrapped marker and were incubated 
at 37°C in the presence of rat plasma for 24 h. At different 
time intervals, CF latency values and distribution of vesi- 
cles size were determined. Almost no leakage was ob- 
served in any of the assayed preparations. After 24 h of 
incubation CF latency values of 94.2% + 0.13 and 96.7% 
+ 2.01 were found for uncoated and C-H coated vesicles, 
respectively. On the other hand, although the size distribu- 
tion was rather broad, the mean vesicle size of both 
preparations did not increase during the time of the experi- 
ment. Moreover, a slight tendency to a decrease in vesicles 
diameter was observed for both preparations. 
There are other examples in the literature in which 
certain liposome formulations, such as liposomes com- 
posed of PS [14] or coated with O-palmitoylamylopectin 
or O-palmitoylpullulan [15], are rapidly removed from 
circulation and accumulate in liver and alveolar 
macrophages respectively. In the case of collagen-coated 
liposomes, the rapid removal from the blood vessels might 
be due to an opsonic effect, either directly induced by 
collagen or by some opsonic protein such as fibronectin. 
This glycoprotein can be found in extracellular matrices, 
on cell surfaces or circulating in blood [33] and it has been 
postulated to have opsonic effect on liposomes after i.v. 
administration [34]. On the other hand, it is known that 
collagen presents ome binding sites for fibronectin and 
that the binding of the two proteins is the first step on the 
cell adhesion process [35]. Therefore, it is possible that 
circulating fibronectin binds to the collagen covering the 
vesicles, thus facilitating the uptake and phagocytosis by 
macrophages, mainly located in liver. In fact, Wolff et al. 
[36] demonstrated that fibronectin stimulated macrophages 
to engulf gelatin-coated rythrocytes. 
On the other hand, the liposomes used in this study 
were not expected to be extensively taken up by hepato- 
cytes, since their mean size (~ 200 nm) was substantially 
higher than the average diameter of the fenestrations in the 
liver sinusoidal endothelium (~ 100 nm). Nevertheless, to
discard this possibility some preliminary experiments with 
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a limited number of animals were done to investigate the 
intrahepatic biodistr ibution i rats of col lagen-coated lipo- 
somes. Supporting our first impression, 16 h after adminis- 
tration almost the total dose recovered in l iver was found 
in Kupffer cells. Currently, further studies are being under- 
taken on the intrahepatic distribution of smaller collagen- 
coated liposomes, which have a higher opportunity to end 
up in hepatocytes. 
In summary, it has been demonstrated that the coating 
of l iposome external surface with collagen (average M r 
50000) involves both, a higher stability in vitro and, in 
spite of the hydrophil ic layer, a selective and almost 
immediate accumulation of the vesicles in liver Kupffer 
cells. Such a formulation might be, therefore, most useful 
in the treatment of some infectious diseases located within 
macrophages, as was demonstrated for PS containing lipo- 
somes against intracellular leishmanias [37]. Because of 
their intracellular location, such infections causes serious 
problems to the conventional  antimicrobial therapy. Colla- 
gen-coated l iposomes look promising to overcome most 
problems associated to parasitic diseases to MPS as well as 
for drug-mediated activation of macrophages into tumorici- 
dal, microbicidal or virucidal state. 
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